Abstract
The matrix protein 2 of the influenza A virus (M2 or AM2) is one of the important components of the viral membrane. This protein can form a proton channel in the viral envelope. Owing to its ability to regulate the surrounding pH in endosome, this protein is an attractive target for drug design against influenza A virus. In this minireview, we summarized the current progresses in computational approaches for studying the M2 proton channel. The attention is focused on how protons are conducted through the M2 channel, and how adamantane-based drugs inhibit the channel, as well as how the drug resistance occurs, in hope to further stimulate the in-depth studies of this important area, both experimentally and theoretically.
Keywords: Influenza A virus, M2 proton channel, molecular modeling, molecular dynamics, proton conductance, drug binding site, drug inhibition, drug resistance.
Mini-Reviews in Medicinal Chemistry
Title:Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel
Volume: 12 Issue: 10
Author(s): Jing-Fang Wang and Kuo-Chen Chou
Affiliation:
Keywords: Influenza A virus, M2 proton channel, molecular modeling, molecular dynamics, proton conductance, drug binding site, drug inhibition, drug resistance.
Abstract: The matrix protein 2 of the influenza A virus (M2 or AM2) is one of the important components of the viral membrane. This protein can form a proton channel in the viral envelope. Owing to its ability to regulate the surrounding pH in endosome, this protein is an attractive target for drug design against influenza A virus. In this minireview, we summarized the current progresses in computational approaches for studying the M2 proton channel. The attention is focused on how protons are conducted through the M2 channel, and how adamantane-based drugs inhibit the channel, as well as how the drug resistance occurs, in hope to further stimulate the in-depth studies of this important area, both experimentally and theoretically.
Export Options
About this article
Cite this article as:
Wang Jing-Fang and Chou Kuo-Chen, Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel, Mini-Reviews in Medicinal Chemistry 2012; 12 (10) . https://dx.doi.org/10.2174/138955712802762275
DOI https://dx.doi.org/10.2174/138955712802762275 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Current Alzheimer Research Sigma Receptor Ligands: Possible Application as Therapeutic Drugs and as Radiopharmaceuticals
Current Pharmaceutical Design G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases
Pharmaceutical Nanotechnology Anti-inflammatory Potential of Alkaloids as a Promising Therapeutic Modality
Letters in Drug Design & Discovery A Study of Extrapyramidal Manifestations Accompanying Decompensated Viral Hepatic Cirrhosis Patients
Reviews on Recent Clinical Trials RNA G-Quadruplexes: G-quadruplexes with “U” Turns
Current Pharmaceutical Design C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
CNS & Neurological Disorders - Drug Targets The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
Current Drug Targets Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Adolescent Psychiatry Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine
Current Medicinal Chemistry Summaries of Selected Presentations from the 2012 Annual Meeting of the American Society for Adolescent Psychiatry
Adolescent Psychiatry Mouse Models of Familial Hemiplegic Migraine for Studying Migraine Pathophysiology
Current Neuropharmacology Drug release from ordered mesoporous silicas
Current Pharmaceutical Design Hansch Analysis of Novel Acetamide Derivatives as Highly Potent and Specific MAO-A Inhibitors
Central Nervous System Agents in Medicinal Chemistry Amplicons as Vaccine Vectors
Current Gene Therapy Amygdalar Atrophy in Early Alzheimer’s Disease
Current Alzheimer Research Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?
Current Drug Targets The Amyloid β-Protein Precursor and Alzheimers Disease. Therapeutic Approaches
Current Medicinal Chemistry - Central Nervous System Agents Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry